bioMérieux SA (EYWN)
FSX
Delayed Data
Oct 14, 2026, 06:00 AM
Day's Range
85.0552 wk Range
63.10Overview - EYWN - bioMérieux SA
Key Statistics
Valuation
Enterprise Value
8.83B
P/E (Trailing)
19.75
Price / Sales (TTM)
2.27
Price / Book
2.11
EV / EBITDA
8.40
Profitability
Profit Margin
11.59%
Operating Margin
15.23%
Return on Assets
7.23%
Return on Equity
11.22%
Ownership
Shares Outstanding
117.69M
Float
40.02M
Held by Insiders
66.46%
Held by Institutions
16.73%
Price stats
Beta
0.57
50-Day Avg
72.50
200-Day Avg
83.18
Dividends
Payout Ratio
25.12%
Frequency
Annual
Market Cap - EYWN - bioMérieux SA
Peers - EYWN - bioMérieux SA
Peer Comparison
Compared with companies in Diagnostics & Research listed on FSX.
- EYWNFSXbioMérieux SA9.06BMarket Cap-45.96%52-week change19.76P/E (Trailing)11.59%Profit Margin
- TN8FSXThermo Fisher Scientific Inc.217.48BMarket Cap+23.56%52-week change37.40P/E (Trailing)15.03%Profit Margin
- TN80FSXThermo Fisher Scientific CDR (CAD Hedged)199.57BMarket Cap+18.37%52-week change34.42P/E (Trailing)15.03%Profit Margin
- DAPFSXDanaher Corp.143.12BMarket Cap+5.59%52-week change43.24P/E (Trailing)15.94%Profit Margin
- SONAFSXSony Group Corp. Sponsored ADR121.43BMarket Cap-23.08%52-week change19.81P/E (Trailing)-1.74%Profit Margin
- WX80FSXWuXi AppTec Co., Ltd.67.37BMarket Cap+48.20%52-week change25.52P/E (Trailing)42.25%Profit Margin
- 45EFSXNatera, Inc.49.84BMarket Cap+75.13%52-week change-227.50P/E (Trailing)-7.10%Profit Margin
Profile Summary - EYWN - bioMérieux SA
About
bioMérieux SA is a family-owned French company and a world leader in the field of in vitro diagnostics, founded in 1963 by the Mérieux family. It pioneers, develops, and produces high-quality diagnostic solutions to improve public health worldwide, with a core purpose of making the world a healthier place through…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
